Idexx Laboratories, (IDXX) Climbs 6.76% for June 23

Equities Staff  |

Idexx Laboratories, Inc. (NASDAQ:IDXX) stock was among today's market movers, concluding trading up 6.76% to $355.62 on June 23.

676,169 shares exchanged hands in comparison to the 30-day daily average of 654,076 shares.

The company's stock has climbed 49.41% so far in 2022.

Idexx Laboratories, shares have fluctuated between $318.50 and $706.95 over the past twelve months.

The company expects its next earnings on 2022-07-28.

For technical charts, analysis, and more on Idexx Laboratories, visit the company profile.

About Idexx Laboratories, Inc.

IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries.

To get more information on Idexx Laboratories, Inc. and to follow the company's latest updates, you can visit the company's profile page here: Idexx Laboratories, Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content